199
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Global DNA Methylation and Tumor Suppressor Gene Promoter Methylation and Gastric Cancer Risk in an Omani Arab Population

, , , , &
Pages 417-429 | Published online: 18 Aug 2011

Bibliography

  • Hohenberger P , GretschelS. Gastric cancer. Lancet362 , 305–315 (2003).
  • Choi I , WuT. Epigenetic alterations in gastric carcinogenesis. Cell Res.15(4) , 247–254 (2005).
  • Ministry of Health Sultanate of Oman. Cancer Incidence in Oman 2007. Department of Surveillance and Non-Communicable Disease Control Directorate General of Health Affairs. Muscat, Oman, 28–31 (2009).
  • Baylin SB , HermanJG, GraffJR, VertinoPM, IssaJP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res.72 , 141–196 (1998).
  • Jones PA , LairdPW. Cancer epigenetics comes of age. Nat. Genet.21(2) , 163–167 (1999).
  • Dunn BK . Hypomethylation: one side of a larger picture. Ann. NY Acad. Sci.983 , 28–42 (2003).
  • Feinberg AP , VogelsteinB. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature301(5895) , 89–92 (1983).
  • Gama-Sosa M , SlagelV, TrewynRet al. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res. 11(19) , 6883–6894 (1983).
  • Jurgens B , Schmitz-DragerBJ, SchulzWA. Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. Cancer Res.56(24) , 5698–5703 (1996).
  • Takai D , YagiY, HabibN, SugimuraT, UshijimaT. Hypomethylation of LINE1 retrotransposon in human hepatocellular carcinomas, but not in surrounding liver cirrhosis. Jpn J. Clin. Oncol.30(7) , 306–309 (2000).
  • Fang JY , XiaoSD, ZhuSS, YuanJM, QiuDK, JiangSJ. Relationship of plasma folic acid and status of DNA methylation in human gastric cancer. J. Gastroenterol.32(2) , 171–175 (1997).
  • Cravo M , PintoR, FidalgoPet al. Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma. Gut 39(3) , 434–438 (1996).
  • Toyota M , AhujaN, SuzukiHet al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 59(21) , 5438–5442 (1999).
  • Cheng YY , YuJ, WongYPet al. Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. Br. J. Cancer 97(7) , 895–901 (2007).
  • Ficorella C , CannitaK, RicevutoEet al. P16 hypermethylation contributes to the characterization of gene inactivation profiles in primary gastric cancer. Oncol. Rep. 10(1) , 169–173 (2003).
  • Graziano F , ArduiniF, RuzzoAet al. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer implications for treatment with demethylating drugs. Ann. Oncol. 15(3) , 489–492 (2004).
  • Kim TY , LeeHJ, HwangKSet al. Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab. Invest. 84(4) , 479–484 (2004).
  • Li QL , ItoK, SakakuraCet al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109(1) , 113–124 (2002).
  • Strathdee G . Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin. Cancer Biol.12(5) , 373–379 (2002).
  • Tamura G . Promoter methylation status of tumor suppressor and tumor-related genes in neoplastic and non-neoplastic gastric epithelia. Histol. Histopathol.19(1) , 221–228 (2004).
  • Tamura G . Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J. Gastroenterol.12(2) , 192–198 (2006).
  • Sakakura C , HamadaT, MiyagawaKet al. Quantitative analysis of tumor-derived methylated RUNX3 sequences in the serum of gastric cancer patients. Anticancer Res. 29(7) , 2619–2625 (2009).
  • Vogiatzi P , VindigniC, RovielloF, RenieriA, GiordanoA. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. J. Cell. Physiol.211(2) , 287–295 (2007).
  • Lima EM , LealMF, BurbanoRRet al. Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer. Braz. J. Med. Biol. Res. 41(6) , 539–543 (2008).
  • Fenoglio-Preiser CM , WangJ, StemmermannGN, NoffsingerA. TP53 and gastric carcinoma: a review. Hum. Mutat.21(3) , 258–270 (2003).
  • Christman JK , SheikhnejadG, DizikM, AbileahS, WainfanE. Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. Carcinogenesis14(4) , 551–557 (1993).
  • Greenblatt MS , BennettWP, HollsteinM, HarrisCC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res.54(18) , 4855–4878 (1994).
  • Pogribny IP , PoirierLA, JamesSJ. Differential sensitivity to loss of cytosine methyl groups within the hepatic p53 gene of folate/methyl deficient rats. Carcinogenesis16(11) , 2863–2867 (1995).
  • Woodson K , MasonJ, ChoiSWet al. Hypomethylation of p53 in peripheral blood DNA is associated with the development of lung cancer. Cancer Epidemiol. Biomarkers Prev. 10(1) , 69–74 (2001).
  • Wainfan E , PoirierLA. Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. Cancer Res.52(Suppl. 7) , S2071–S2077 (1992).
  • Sugai T , HabanoW, EndohMet al. Molecular analysis of gastric differentiated-type intramucosal and submucosal cancers. Int. J. Cancer 127(11) , 2500–2509 (2010).
  • Hou L , WangH, SartoriSet al. Blood leukocyte DNA hypomethylation and gastric cancer risk in a high-risk Polish population. Int. J. Cancer 127(8) , 1866–1874 (2010).
  • Hsiung DT , MarsitCJ, HousemanEAet al. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 16(1) , 108–114 (2007).
  • Moore LE , PfeifferRM, PoscabloCet al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case–control study. Lancet Oncol. 9(4) , 359–366 (2008).
  • An Q , LiuY, GaoYet al. Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients. Cancer Lett. 188(1–2) , 109–114 (2002).
  • Bastian PJ , PalapattuGS, LinXet al. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy. Clin. Cancer Res. 11(11) , 4037–4043 (2005).
  • Goessl C , MullerM, HeicappellR, KrauseH, MillerK. DNA-based detection of prostate cancer in blood, urine, and ejaculates. Ann. NY Acad. Sci.945 , 51–58 (2001).
  • Goessl C , MullerM, StraubB, MillerK. DNA alterations in body fluids as molecular tumor markers for urological malignancies. Eur. Urol.41(6) , 668–676 (2002).
  • Hsu HS , ChenTP, HungCHet al. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma. Cancer 110(9) , 2019–2026 (2007).
  • Reibenwein J , PilsD, HorakPet al. Promoter hypermethylation of GSTP1, AR, and 14–3–3σ in serum of prostate cancer patients and its clinical relevance. Prostate 67(4) , 427–432 (2007).
  • Ulivi P , ZoliW, CalistriDet al. p16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients. J. Cell. Physiol.206(3) , 611–615 (2006).
  • Abbaszadegan MR , MoavenO, SimaHRet al. p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer. World J. Gastroenterol.14(13) , 2055–2060 (2008).
  • Leung WK , ToKF, ChuESet al. Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer. Br. J. Cancer 92(12) , 2190–2194 (2005).
  • Tan SH , IdaH, LauQCet al. Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3. Oncol. Rep. 18(5) , 1225–1230 (2007).
  • Wang YC , YuZH, LiuCet al. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients. World J. Gastroenterol. 14(19) , 3074–3080 (2008).
  • Ramirez JL , TaronM, BalanaCet al. Serum DNA as a tool for cancer patient management. Rocz. Akad. Med. Bialymst. 48 , 34–41 (2003).
  • Al-Moundhri M , AlkindyM, Al-NabhaniMet al. Combined polymorphism analysis of glutathione S-transferase M1/G1 and interleukin-1B (IL-1B)/interleukin 1-receptor antagonist (IL-1RN) and gastric cancer risk in an Omani Arab Population. J. Clin. Gastroenterol. 43(2) , 152–156 (2009).
  • Al-Moundhri M , Al-ShukailiA, Al-NabhaniMet al. Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma. World J. Gastroenterol. 14(24) , 3879–3883 (2008).
  • Yang AS , EstecioMR, DoshiK, KondoY, TajaraEH, IssaJP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res.32(3) , e38 (2004).
  • Bollati V , BaccarelliA, HouLet al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 67(3) , 876–880 (2007).
  • Shaw RJ , LiloglouT, RogersSNet al. Promoter methylation of P16, RARβ, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br. J. Cancer 94(4) , 561–568 (2006).
  • SAS Institute Inc., SAS 9.2 Reference Manual. SAS Institute Inc., NC, USA (2009).
  • Chalitchagorn K , ShuangshotiS, HourpaiNet al. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23(54) , 8841–8846 (2004).
  • Jiang L , GondaTA, GambleMVet al. Global hypomethylation of genomic DNA in cancer-associated myofibroblasts. Cancer Res. 68(23) , 9900–9908 (2008).
  • Kim YI , ChristmanJK, FleetJCet al. Moderate folate deficiency does not cause global hypomethylation of hepatic and colonic DNA or c-myc-specific hypomethylation of colonic DNA in rats. Am. J. Clin. Nutr. 61(5) , 1083–1090 (1995).
  • Pogribny IP , BasnakianAG, MillerBJ, LopatinaNG, PoirierLA, JamesSJ. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. Cancer Res.55(9) , 1894–1901 (1995).
  • Obe G , JohannesC, Schulte-FrohlindeD. DNA double-strand breaks induced by sparsely ionizing radiation and endonucleases as critical lesions for cell death, chromosomal aberrations, mutations and oncogenic transformation. Mutagenesis7(1) , 3–12 (1992).
  • House MG , GuoM, EfronDTet al. Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behavior. J. Gastrointest. Surg. 7(8) , 1004–1014; discussion 1014 (2003).
  • Al-Moundhri MS , Al-NabhaniM, TarantiniL, BaccarelliA, RusieckiJA. The prognostic significance of whole blood global and specific DNA methylation levels in gastric adenocarcinoma. PLoS ONE5(12) , e15585 (2010).
  • Yamada H , ShinmuraK, GotoMet al. Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients. Mol. Cancer 8(63) , 63 (2009).
  • Yoo EJ , ParkSY, ChoNYet al. Influence of IL1B polymorphism on CpG island hypermethylation in Helicobacter pylori-infected gastric cancer. Virchows Arch. 456(6) , 647–652 (2010).
  • Shin CM , KimN, JungYet al. Role of Helicobacter pylori infection in aberrant DNA methylation along multistep gastric carcinogenesis. Cancer Sci. 101(6) , 1337–1346 (2010).
  • Al Riyami AA , AfifiM. Smoking in Oman: prevalence and characteristics of smokers. East Mediterr. Health J.10(4–5) , 600–609 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.